Clinical Trial Update: A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7507062 in participants with systemic lupus e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• RO7507062

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING